Clinical Chemistry and Laboratory Medicine – Page 5

Contribution of SuPAR for patients in a situation of uncertainty downstream of emergenciesMarina Brailovaon January 8, 2026 at 11:00 am

January 9, 2026 by ccinfoadmin

Clin Chem Lab Med. 2026 Jan 9. doi: 10.1515/cclm-2025-1101. Online ahead of print. ABSTRACT OBJECTIVES: Evolution is difficult to predict for some patients at emergency department (ED). The soluble urokinase plasminogen activator receptor (suPAR) is a non-specific prognostic inflammatory blood biomarker with a high negative predictive value for pejorative outcomes. The aim of this study … Read more

Secondary use of external quality assessment data – estimating inter-assay variation in LOINC-coded datasetsMichael Vogeseron January 7, 2026 at 11:00 am

January 7, 2026 by ccinfoadmin

Clin Chem Lab Med. 2026 Jan 8. doi: 10.1515/cclm-2025-1695. Online ahead of print. ABSTRACT The secondary scientific use of routine laboratory data will increasingly rely on LOINC as a semantic standard, particularly within the European Health Data Space (EHDS). LOINC enables the aggregation of large data sets from clinical care for research purposes, particularly in … Read more

Comparison of blood sample quality and test results between robotic and manual venipuncture: a pilot studyRong Wangon January 7, 2026 at 11:00 am

January 7, 2026 by ccinfoadmin

Clin Chem Lab Med. 2026 Jan 8. doi: 10.1515/cclm-2025-1126. Online ahead of print. ABSTRACT OBJECTIVES: This study aimed to evaluate the feasibility of robotic venipuncture in clinical settings and compare its performance with manual venipuncture in terms of blood specimen quality and test results. METHODS: From March to April 2025, 63 participants (35 females, 28 … Read more

Cryoproteins: a rare cryofibrinogenemia caseAnn Amvuyele Masetion January 6, 2026 at 11:00 am

January 7, 2026 by ccinfoadmin

Clin Chem Lab Med. 2026 Jan 7. doi: 10.1515/cclm-2025-1552. Online ahead of print. NO ABSTRACT PMID:41492881 | DOI:10.1515/cclm-2025-1552

Evaluation of the MAGLUMI non-competitive angiotensin I chemiluminescence immunoassay for measuring renin activity in human plasmaLina Wuon January 6, 2026 at 11:00 am

January 7, 2026 by ccinfoadmin

Clin Chem Lab Med. 2026 Jan 7. doi: 10.1515/cclm-2025-1361. Online ahead of print. ABSTRACT OBJECTIVES: Plasma renin activity (PRA) measures the rate of renin converting angiotensinogen to angiotensin I in circulation and reflects the function of renin-angiotensin-aldosterone system (RAAS). The study aimed to demonstrate the performance of the MAGLUMI Angiotensin I assay for the measurement … Read more

Assessment of drone transport for biological samples: a real-world experience at a tertiary hospitalPaula Calomarde-Pastoron January 5, 2026 at 11:00 am

January 5, 2026 by ccinfoadmin

Clin Chem Lab Med. 2026 Jan 6. doi: 10.1515/cclm-2025-1205. Online ahead of print. ABSTRACT OBJECTIVES: Our aim is to determine whether drone transport introduces relevant variability in analytical results and to assess its suitability for integration into routine hospital laboratory operations. METHODS: A two-phase study was conducted. The stability phase involved three sets of samples … Read more

Applying the Implementation Science to the harmonization of laboratory test results in the changing landscapeMauro Panteghinion January 4, 2026 at 11:00 am

January 5, 2026 by ccinfoadmin

Clin Chem Lab Med. 2026 Jan 6. doi: 10.1515/cclm-2025-1632. Online ahead of print. ABSTRACT Nowadays, we are facing major changes in the landscape of test harmonization through metrological traceability approach, all expected to promote equivalence of reported laboratory results. However, having traceability tools in place does not automatically mean that metrological traceability is correctly implemented. … Read more

Measurement of lipoprotein(a) via a novel point of care approach with comparison to established laboratory assaysCaroline A E Bachmeieron January 4, 2026 at 11:00 am

January 5, 2026 by ccinfoadmin

Clin Chem Lab Med. 2026 Jan 6. doi: 10.1515/cclm-2025-1605. Online ahead of print. ABSTRACT OBJECTIVES: Lipoprotein(a) is an atherogenic particle causative of atherosclerotic cardiovascular disease. Novel treatments have been developed that lower lipoprotein(a) to unprecedented levels with cardiovascular outcomes trials ongoing. Many guidelines recommend testing once in the lifetime of everyone, but testing rates remain … Read more

From venipuncture to self-sampling dried blood spots: a shift in monitoring testosterone levelsAnouk Olthofon January 3, 2026 at 11:00 am

January 3, 2026 by ccinfoadmin

Clin Chem Lab Med. 2026 Jan 5. doi: 10.1515/cclm-2025-1287. Online ahead of print. ABSTRACT OBJECTIVES: Dried blood spot (DBS) sampling enables convenient at-home blood collection, suitable for patients needing regular check-ups, such as those receiving testosterone replacement therapy (TRT). This study assessed the feasibility and reliability of DBS sampling for monitoring testosterone concentrations in patients … Read more

Validation study of the Helena V8 UltraCE capillary elecrophoresis analyserJoris R Delangheon January 2, 2026 at 11:00 am

January 3, 2026 by ccinfoadmin

Clin Chem Lab Med. 2026 Jan 5. doi: 10.1515/cclm-2025-1523. Online ahead of print. ABSTRACT OBJECTIVES: Serum protein electrophoresis is one of the keystone investigations for screening for monoclonal proteins and assessing the serum protein profile. The newly released Helena V8ultra capillary electrophoresis system has been evaluated. METHODS: In total, 164 serum samples were assessed on … Read more